{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:20:34Z","timestamp":1783351234740,"version":"3.54.6"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,12]]},"DOI":"10.7759\/cureus.83972","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T18:20:55Z","timestamp":1747074055000},"source":"Crossref","is-referenced-by-count":2,"title":["Carpal Tunnel Syndrome Attributed to Medication Use: A Pharmacovigilance Study"],"prefix":"10.7759","author":[{"given":"Andrew","family":"Mihalache","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Volfson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Persitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Carpal tunnel syndrome","author":"Sevy JO","year":"2024","unstructured":"Sevy JO, Sina RE, Varacallo M. Carpal tunnel syndrome. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2009.09.019","article-title":"Dynamics of intracarpal tunnel pressure in patients with carpal tunnel syndrome","volume":"35","author":"Goss BC","year":"2010","unstructured":"Goss BC, Agee JM. Dynamics of intracarpal tunnel pressure in patients with carpal tunnel syndrome. J Hand Surg Am. 2010, 35:197-206. 10.1016\/j.jhsa.2009.09.019","journal-title":"J Hand Surg Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/aian.AIAN_148_21","article-title":"A clinical and neurophysiological analysis of idiopathic carpal tunnel syndrome with respect to gender and occupation","volume":"24","author":"Mathew AE","year":"2021","unstructured":"Mathew AE, John T. A clinical and neurophysiological analysis of idiopathic carpal tunnel syndrome with respect to gender and occupation. Ann Indian Acad Neurol. 2021, 24:865-72. 10.4103\/aian.AIAN_148_21","journal-title":"Ann Indian Acad Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2174\/1874325001206010069","article-title":"Carpal tunnel syndrome: a review of the recent literature","volume":"6","author":"Ibrahim I","year":"2012","unstructured":"Ibrahim I, Khan WS, Goddard N, Smitham P. Carpal tunnel syndrome: a review of the recent literature. Open Orthop J. 2012, 6:69-76. 10.2174\/1874325001206010069","journal-title":"Open Orthop J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2004.01.002","article-title":"Individual risk factors for carpal tunnel syndrome: an evaluation of body mass index, wrist index and hand anthropometric measurements","volume":"106","author":"Boz C","year":"2004","unstructured":"Boz C, Ozmenoglu M, Altunayoglu V, Velioglu S, Alioglu Z. Individual risk factors for carpal tunnel syndrome: an evaluation of body mass index, wrist index and hand anthropometric measurements. Clin Neurol Neurosurg. 2004, 106:294-9. 10.1016\/j.clineuro.2004.01.002","journal-title":"Clin Neurol Neurosurg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsb.2004.02.009","article-title":"Risk factors in carpal tunnel syndrome","volume":"29","author":"Geoghegan JM","year":"2004","unstructured":"Geoghegan JM, Clark DI, Bainbridge LC, Smith C, Hubbard R. Risk factors in carpal tunnel syndrome. J Hand Surg Br. 2004, 29:315-20. 10.1016\/j.jhsb.2004.02.009","journal-title":"J Hand Surg Br"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.0236","article-title":"Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial","volume":"27","author":"Sestak I","year":"2009","unstructured":"Sestak I, Sapunar F, Cuzick J. Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial. J Clin Oncol. 2009, 27:4961-5. 10.1200\/JCO.2009.22.0236","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1085-9489.2003.03026.x","article-title":"Carpal tunnel syndrome and oral contraceptive drugs: risk or protective factor?","volume":"8","author":"Albani G","year":"2003","unstructured":"Albani G, Priano L, Campanelli L, Pignatti R, Liuzzi A, Galloti P, Mauro A. Carpal tunnel syndrome and oral contraceptive drugs: risk or protective factor?. J Peripher Nerv Syst. 2003, 8:207-8. 10.1111\/j.1085-9489.2003.03026.x","journal-title":"J Peripher Nerv Syst"},{"key":"ref9","unstructured":"FDA Adverse Event Reporting System (FAERS) public dashboard. (2023). https.\/\/www.fda.gov\/drugs\/fdas-adverse-event-reporting-system-faers\/fda-adverse-event-reporting-system-faers-public-d...."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.04037.x","article-title":"Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database","volume":"72","author":"Montastruc JL","year":"2011","unstructured":"Montastruc JL, Sommet A, Bagheri H, Lapeyre-Mestre M. Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. Br J Clin Pharmacol. 2011, 72:905-8. 10.1111\/j.1365-2125.2011.04037.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans SJ","year":"2001","unstructured":"Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001, 10:483-6. 10.1002\/pds.677","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730070-00011","article-title":"Bayesian confidence propagation neural network","volume":"30","author":"Bate A","year":"2007","unstructured":"Bate A. Bayesian confidence propagation neural network. Drug Saf. 2007, 30:623-5. 10.2165\/00002018-200730070-00011","journal-title":"Drug Saf"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000004378","article-title":"Necrotic granulomatous inflammation after use of small intestine submucosa matrix for recurrent compression neuropathy","volume":"10","author":"Koenig ZA","year":"2022","unstructured":"Koenig ZA, Burns JC, Hayes JD. Necrotic granulomatous inflammation after use of small intestine submucosa matrix for recurrent compression neuropathy. Plast Reconstr Surg Glob Open. 2022, 10:e4378. 10.1097\/GOX.0000000000004378","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2022.07.016","article-title":"Long-term open-label extension study of the safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II","volume":"137","author":"Muenzer J","year":"2022","unstructured":"Muenzer J, Burton BK, Harmatz P, et al.. Long-term open-label extension study of the safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II. Mol Genet Metab. 2022, 137:92-103. 10.1016\/j.ymgme.2022.07.016","journal-title":"Mol Genet Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01982-3","article-title":"Functional results after carpal tunnel release in mucopolysaccharidosis","volume":"16","author":"Giostri GS","year":"2021","unstructured":"Giostri GS, Souza CD, Nagai AK, Santos ML, Sampaio JS Neto, de Masi Nassif FD. Functional results after carpal tunnel release in mucopolysaccharidosis. Orphanet J Rare Dis. 2021, 16:382. 10.1186\/s13023-021-01982-3","journal-title":"Orphanet J Rare Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009354.pub5","article-title":"Enzyme replacement therapy with laronidase (Aldurazyme(\u00ae)) for treating mucopolysaccharidosis type I","volume":"6","author":"Jameson E","year":"2019","unstructured":"Jameson E, Jones S, Remmington T. Enzyme replacement therapy with laronidase (Aldurazyme(\u00ae)) for treating mucopolysaccharidosis type I. Cochrane Database Syst Rev. 2019, 6:CD009354. 10.1002\/14651858.CD009354.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-018-0242-8","article-title":"Clinical effectiveness of enzyme replacement therapy with galsulfase in mucopolysaccharidosis type VI treatment: systematic review","author":"Gomes DF","year":"2018","unstructured":"Gomes DF, Gallo LG, Leite BF, Silva RB, da Silva EN. Clinical effectiveness of enzyme replacement therapy with galsulfase in mucopolysaccharidosis type VI treatment: systematic review. J Inherit Metab Dis. 2018, 10.1007\/s10545-018-0242-8","journal-title":"J Inherit Metab Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002897","article-title":"Tesamorelin improves fat quality independent of changes in fat quantity","volume":"35","author":"Lake JE","year":"2021","unstructured":"Lake JE, La K, Erlandson KM, et al.. Tesamorelin improves fat quality independent of changes in fat quantity. AIDS. 2021, 35:1395-402. 10.1097\/QAD.0000000000002897","journal-title":"AIDS"},{"key":"ref19","unstructured":"Tesamorelin monograph for professionals. Accessed. December 21, 2024: https:\/\/www.drugs.com\/monograph\/tesamorelin.html."},{"key":"ref20","article-title":"Physiology, growth hormone","author":"Brinkman JE","year":"2024","unstructured":"Brinkman JE, Tariq MA, Leavitt L, Sharma S. Physiology, growth hormone. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1053\/apmr.2000.7159","article-title":"Bilateral median neuropathy and growth hormone use: a case report","volume":"81","author":"Dickerman RD","year":"2000","unstructured":"Dickerman RD, Douglas JA, East JW. Bilateral median neuropathy and growth hormone use: a case report. Arch Phys Med Rehabil. 2000, 81:1594-5. 10.1053\/apmr.2000.7159","journal-title":"Arch Phys Med Rehabil"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2010.515977","article-title":"Anastrozole","volume":"9","author":"Kelly CM","year":"2010","unstructured":"Kelly CM, Buzdar AU. Anastrozole. Expert Opin Drug Saf. 2010, 9:995-1003. 10.1517\/14740338.2010.515977","journal-title":"Expert Opin Drug Saf"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.4005","article-title":"Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome","volume":"26","author":"Morales L","year":"2008","unstructured":"Morales L, Pans S, Verschueren K, et al.. Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome. J Clin Oncol. 2008, 26:3147-52. 10.1200\/JCO.2007.15.4005","journal-title":"J Clin Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.4972","article-title":"Anastrozole-induced carpal tunnel syndrome: results from the International Breast Cancer Intervention Study II prevention trial","volume":"34","author":"Spagnolo F","year":"2016","unstructured":"Spagnolo F, Sestak I, Howell A, Forbes JF, Cuzick J. Anastrozole-induced carpal tunnel syndrome: results from the International Breast Cancer Intervention Study II prevention trial. J Clin Oncol. 2016, 34:139-43. 10.1200\/JCO.2015.63.4972","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9020566","article-title":"Aromatase inhibitors and risk of arthritis and carpal tunnel syndrome among Taiwanese women with breast cancer: a nationwide claims data analysis","volume":"9","author":"Chien HC","year":"2020","unstructured":"Chien HC, Kao Yang YH, Kwoh CK, Chalasani P, Wilson DL, Lo-Ciganic WH. Aromatase inhibitors and risk of arthritis and carpal tunnel syndrome among Taiwanese women with breast cancer: a nationwide claims data analysis. J Clin Med. 2020, 9:566. 10.3390\/jcm9020566","journal-title":"J Clin Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200161070-00010","article-title":"Alendronate: an update of its use in osteoporosis","volume":"61","author":"Sharpe M","year":"2001","unstructured":"Sharpe M, Noble S, Spencer CM. Alendronate: an update of its use in osteoporosis. Drugs. 2001, 61:999-1039. 10.2165\/00003495-200161070-00010","journal-title":"Drugs"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146772","article-title":"Carpal tunnel syndrome associated with oral bisphosphonates. A population-based cohort study","volume":"11","author":"Carvajal A","year":"2016","unstructured":"Carvajal A, Mart\u00edn Arias LH, S\u00e1inz M, et al.. Carpal tunnel syndrome associated with oral bisphosphonates. A population-based cohort study. PLoS One. 2016, 11:e0146772. 10.1371\/journal.pone.0146772","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/9.1.285","article-title":"Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings","volume":"9","author":"Mamelak M","year":"1986","unstructured":"Mamelak M, Scharf MB, Woods M. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep. 1986, 9:285-9. 10.1093\/sleep\/9.1.285","journal-title":"Sleep"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.shaw.2014.01.003","article-title":"Meta-analysis: association between wrist posture and carpal tunnel syndrome among workers","volume":"5","author":"You D","year":"2014","unstructured":"You D, Smith AH, Rempel D. Meta-analysis: association between wrist posture and carpal tunnel syndrome among workers. Saf Health Work. 2014, 5:27-31. 10.1016\/j.shaw.2014.01.003","journal-title":"Saf Health Work"},{"key":"ref30","unstructured":"Gamma hydroxybutyrate (GHB) Fact Sheet | Office of Justice Programs. Accessed. December 21, 2024: https:\/\/www.ojp.gov\/ncjrs\/virtual-library\/abstracts\/gamma-hydroxybutyrate-ghb-fact-sheet.."},{"key":"ref31","article-title":"Tafamidis","author":"Verma B","year":"2024","unstructured":"Verma B, Patel P. Tafamidis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12451","article-title":"The neuropathy in hereditary transthyretin amyloidosis: a narrative review","volume":"26","author":"Tozza S","year":"2021","unstructured":"Tozza S, Severi D, Spina E, et al.. The neuropathy in hereditary transthyretin amyloidosis: a narrative review. J Peripher Nerv Syst. 2021, 26:155-9. 10.1111\/jns.12451","journal-title":"J Peripher Nerv Syst"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.230671","article-title":"Hereditary transthyretin amyloidosis presenting with carpal tunnel syndrome","volume":"196","author":"Zaki N","year":"2024","unstructured":"Zaki N, Miller NJ, Frosk P, Sharma A. Hereditary transthyretin amyloidosis presenting with carpal tunnel syndrome. CMAJ. 2024, 196:E95-9. 10.1503\/cmaj.230671","journal-title":"CMAJ"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/369062-carpal-tunnel-syndrome-attributed-to-medication-use-a-pharmacovigilance-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T18:20:57Z","timestamp":1747074057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/369062-carpal-tunnel-syndrome-attributed-to-medication-use-a-pharmacovigilance-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.83972","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,12]]}}}